CELLULITIS.

Slides:



Advertisements
Similar presentations
Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Advertisements

Linezolid-Induced Anemia in a Patient with Osteomyelitis
Diabetes Mellitus.
DR. TARIK Y. ZAMZAMI MD, CABOG, FICS ASSOCIATE PROFESSOR CONSULTANT OB/GYN
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Assessment and Management of Patients With Diabetes Mellitus Prepared by Dr. ImanAbdullah.
COMMON LIFESTYLE DISEASES
Oral Glucose Tolerance Test By: Dr. Beenish Zaki Date: 09/05/2012 Senior Instructor Department of Biochemistry.
Hba1c for diagnosis Dr Karen Adamson. β-chain α-chain Glucose bound to N-terminal valine of β-chain.
LONG TERM BENEFITS OF ORAL AGENTS
DIABETES MELLITUS DR. J. PRATHEEBA DEVI. Definition Definition Diabetes is a metabolic disorder characterized by raised levels of glucose in the blood.
DIABETES Power over Diabetes Presented by: Regina Weitzman, MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Non-pharmacologic Elevate the affected area to facilitate gravity drainage of edema and inflammatory substances – Patients with edema may benefit from.
Adult Medical-Surgical Nursing
Better Health. No Hassles. Type 2 Diabetes. Better Health. No Hassles. TYPE 2 DIABETES Chronic condition that affects the way your body metabolizes sugar.
Diabetes Mellitus Diabetes Mellitus is a group of metabolic diseases characterized by elevated levels of glucose in blood (hyperglycemia) Diabetes Mellitus.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
CARE OF PATIENTS WITH DIABETES MELLITUS JANNA WICKHAM RN MSN LSSC FALL 2013 Chapter 20.
Chapter 24 Chapter 24 Exercise Management.  Diabetes is a chronic metabolic disease characterized by an absolute or relative deficiency of insulin that.
Diabetic Ketoacidosis DKA)
Nursing Care of Clients with Diabetes Mellitus.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Plasma Glucose. Glucose Glucose (MW: ) is a very important fuel source to generate universal energy molecules (ATP). Blood glucose regulation I-
Estimation of blood glucose in diabetes mellitus.
DIABETES MELLITUS IN CHILDREN: CLINICAL FEATURES, DIAGNOSTICS AND TREATMENT Prof. H.A. Pavlyshyn.
DIABETES MELLITUS IN CHILDREN. Blood glucose Apart from transient illness-induced or stress-induced hyperglycemia, a random whole-blood glucose.
Diabetes mellitus (DM), also known simply as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period.
Module 7 Caring for Children with Alterations in Metabolism - Endocrine Chapter 29.
Copyright © 2012 The McGraw-Hill Companies. All Rights Reserved. Chapter 11 - Chronic Diseases.
Osteomyelitis Dr. Belal Hijji, RN, PhD March 14, 2012.
Nursing Management: Diabetes Mellitus
Glucose Control and Monitoring
Clinical Practice Glycemic Management of Type 2 Diabetes Mellitus Faramarz Ismail-Beigi, M.D., Ph.D. Dr.kalantar N Engl J Med Volume 366(14):
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Dr. Nathasha Luke.  Define the term glucose homeostasis  Describe how blood glucose levels are maintained in the fasting state and fed state  Describe.
Diabetes ABCs Diabetes Care Centers Henry Ford Health Systems.
DIABETIC TEACHING VERMALYNPAULETTEMICHELLEEDWARD.
Source:
Big Group Discussion Group C3B Malig-Marayag Facial Cellulitis in a Diabetic.
Diabetes Mellitus Ch 13 ~ Endocrine System Med Term.
Dixie L. Thompson chapter 20 Exercise and Diabetes.
PLANS CBC Blood Chemistry – creatinine – Lipid profile – HBA1c – Sodium – Potassium Arterial Blood Gas.
Diabetes in Pregnancy Diabetes: a leading complication in pregnancy Forms of diabetes include: –Type 1 diabetes—Results from destruction of insulin-producing.
Diabetes Mellitus: Prevention & Treatment Medical surgical in nursing /02/01.
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
Chapter Exercise and Diabetes Dixie L. Thompson C H A P T E R.
Diabetic Profile Measurement of Blood Glucose T.A. Bahiya Osrah.
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
Lab (7): Diabetic profile
Background notes Audience: diabetes professional (entry level), patients with diabetes First slide: ADD your name/institution ‘Sponge bob’ slide: hemoglobin.
Estimation of blood glucose in diabetes mellitus.
Warm Up: 1.What 2 things do you need to do to maintain a healthy weight or lose weight? 2.What are the 3 types of Diabetes? 3.What causes Diabetes? 1.
DEVELOPED IN PART BY THE COMMUNITY WELLNESS TEAM Diabetes GETTING STARTED.
Diabetes affects more than 20 million Americans. Over 40 million Americans have prediabetes.
Estimation of blood glucose in diabetes mellitus
Endocrine System KNH 411.
Diabetes Health Status Report
Endocrine System KNH 411.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Endocrine System KNH 411.
Diabetes.
Hba1c for diagnosis Dr Karen Adamson.
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
Presentation transcript:

CELLULITIS

Figure 1 Diagnostic evaluation of skin and soft tissue infections (SSTIs). *As clinically indicated; †Ulcerated lesions should be cleaned and debrided before having wound base swabbed; ‡Most useful if vesicle/bullae or fluid abscess present; §Seek out bone trauma and air fluid levels; ¶Indications –neurological deficits, vision nonassessable, proptosis/deteriorating acuity or colour/bilateral edema/ophthalmoplegia, no improvement after 24 h and swinging pyrexia not resolving within 36 h (for head only); **Only if central nervous system involvement suspected and intracranial pressure excluded. CT Computed tomography; MRI Magnetic resonance imaging *As clinically indicated; †Ulcerated lesions should be cleaned and debrided before having wound base swabbed; ‡Most useful if vesicle/bullae or fluid abscess present; §Seek out bone trauma and air fluid levels; ¶Indications –neurological deficits, vision nonassessable, proptosis/deteriorating acuity or colour/bilateral edema/ophthalmoplegia, no improvement after 24 h and swinging pyrexia not resolving within 36 h (for head only); **Only if central nervous system involvement suspected

Diagnosis Clinical diagnosis Fine Needle Aspiration Technique Leading edge injection and aspiration with saline Efficacy May assist diagnosis with cellulitis Not useful in Erysipelas 30% sensitivity from closed lesions Indication Unusual pathogens suspected Cellulitis refractory to current antibiotics Blood Culture (25% sensitivity) only 20% of cases are positive Skin biopsy (25% sensitivity) www.fpnotebook.com/DER/Endo/SknInfctnsInDbtsMlts.html and Harrison’s 17th ed 5

Diagnosis Based on appearance of the skin and patient history Drainage from an abscess or weeping wound associated with cellulitis should be sent for culture and sensitivities. Material from needle aspiration of inflamed skin or skin biopsy can be cultured in cases of cellulitis without purulence, abscess, or a necrotic Indications for blood cultures include significant fever and chills, severe immunocompromise, periorbital cellulitis, and cellulitis superimposed on lymphedema. A polymorphonuclear leukocytosis is often present with cellulitis; a complete blood cell count and differential may help gauge the severity of infection and the hematologic response.

Goals of therapy DM Cellulits Eliminate symptoms related to hyperglycemia Reduce or eliminate the long-term microvascular and macrovascular complications of DM Allow the patient to achieve as normal a lifestyle as possible treat the affected area and any underlying conditions that would increase the chance of cellulitis returning Harrisons 17th ed http://skin.emedtv.com/cellulitis/cellulitis-treatment.html 7

oral therapy for mild infections intravenous therapy for severe infections achievement of high drug levels with rapid delivery.

http://www. pubmedcentral. nih. gov/articlerender. fcgi http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2605859&tool=pmcentrez

Therapeutic approach Non-pharmacologic Pharmacologic Rest affected area, elevate the area of the body involved (this will help decrease swelling and relieve discomfort) Clean wound site Cellulitis in a DM patient Early or Mild disease Augmentin 875 mg PO bid Second Generation Cephalosporin (cefoxitin, cefacor, cefuroxime) Third Generation Cephalosporin (cefotaxime, ceftazidime,m ceftriaxone, cefixime) Severe disease Imipenem-Cilastatin (Primaxin) Meropenem Trovafloxacin IV Augmentin: amoxicillin/potassium clavulanate – b-lactams inihibit bacterial growth by interfering with the transpeptidation reaction of bacterial cell wall synthesis the clavulanate extends the spectrum of amoxycillin to embrace a wider range of organisms, including many resistant to other ß-lactam antibiotics.  Cephalosporins: similar to penicillin just more stable to many bacterial b-lactamases therefore have broader spectrum of activity. 2nd- more gram – effect Imipenem-cilastatin: imipenem has wide spectrum with good activity against many gram-negative rods, inc. P.aeruginosa. Resitant to most b-lactamases except metallo-b-lactamases. Imipenem is inactivated by dehydropeptidases in renal tubules, resulting in low urinary conc. So it must be administered with cilastatin(inhibitor of renal dehydropeptidase) Meropenem: similar to imipenem but slightly greater activity against gram – aerobes and slightly less activity with gram + rovafloxacin (sold as Trovan by Pfizer and Turvel by Laboratorios Almirall) is a broad spectrum antibiotic that inhibits the uncoiling of supercoiled DNA in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV.[1] It was withdrawn from the market due to the risk of hepatotoxicity. It had better gram-positive bacterial coverage and less gram-negative coverage than the previous fluoroquinolones. www.emedicinehealth.com/cellulitis www.fpnotebook.com/DER/Endo/SknInfctnsInDbtsMlts.htm 10

Management: Facial Cellulitis Mild to Moderate Infection Augmentin 875 mg PO bid Cefazolin (Ancef) 1 g IV every 8 hours Severe Infection Nafcillin 2 g IV every 4 hours Oxacillin 2 g IV every 4 hours Vancomycin 1.0-1.5 g IV qd Linezolid

In a study by Kohno et al, Linezolid was compared with vancomycin; both had a comparable clinical success rate in the treatment of SSTi. In the lab tests done after the end of the treatment and during follow up, Linezolid had a better microbial eradication rate. Also, for the adverse effects (hematologic), linezolid was safer. S. Kohno1, K. Yamaguchi2, et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant. Staphylococcus aureus in Japan. Journal of Antimicrobial Chemotherapy 2007 60(6):1361-1369; doi:10.1093/jac/dkm369 http://jac.oxfordjournals.org/cgi/content/full/60/6/1361

Vancomycin is distributed widely to various tissues and body fluids, however in patient with DM, its penetration in soft tissues is greatly impaired AUSkhirtladze K; Hutschala D; Fleck T; Thalhammer F; Ehrlich M; Vukovich T; Muller M; Tschernko. Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. EM SOAntimicrob Agents Chemother. 2006 Apr;50(4):1372-5. http://www.uptodate.com/patients/content/abstract.do;jsessionid=F7D4E0E035890469420995852E59E973.1102?topicKey=~aa8X1QFoqoQSyT&refNum=8 http://www.uptodate.com/patients/content/topic.do?topicKey=~aa8X1QFoqoQSyT

In a study by Stein et al, Linezolid was effective in the treatment of Staphylococcus aureus in diabetic patients G E. Stein1,* S Schooley1, et al. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm271 http://jac.oxfordjournals.org/cgi/content/full/dkm271v1

Duration of therapy response to drug therapy follow-up is of utmost importance 10 to 14 days of antibiotic therapy Absence of response/worsening after five days of the initiation of therapy prompts a change in the antibiotic regimen or other investigations to verify the diagnosis

Preventing a recurrence of cellulitis Cellulitis tends to recur in people with certain medical conditions that can lead to skin breakdown, such as edema (fluid buildup), fungal or bacterial infections, diabetes, or peripheral arterial disease. edema, support stockings and good skin hygiene may reduce or eliminate recurrence of cellulitis. fungal infections, regular use of antifungal medicines may help reduce recurrent cellulitis. high risk for recurring cellulitis, (when with open wound or cut) taking preventive antibiotics may help http://www.everettclinic.com/kbase/topic/mini/tr5105/treatmnt.htm

Vincent Ki, MD and Coleman Rotstein, MD Vincent Ki, MD and Coleman Rotstein, MD. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008 March; 19(2): 173-184.

DIABETES MELLITUS

DIAGNOSTIC TEST FOR DIABETES MELLITUS 19

Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and is diagnosed by demonstrating any one of the following: Fasting plasma glucose level at or above 126 mg/dL (7.0 mmol/L). Plasma glucose at or above 200 mg/dL (11.1 mmol/L) two hours after a 75 g oral glucose load as in a glucose tolerance test. Symptoms of hyperglycemia and plasma glucose at or above 200 mg/dL (11.1 mmol/L). 20

Fasting blood glucose test The most common test for diagnosis of diabetes. blood glucose levels are checked after fasting for between 12 and 14 hours. Patients with fasting glucose levels from 100 to 125 mg/dL (6.1 and 7.0 mmol/L) are considered to have impaired fasting glucose Patients with diabetes may be asked to delay their diabetes medication or insulin dose until the test is completed. The fasting blood glucose test will confirm that the person has diabetes if it shows that the level of glucose in their blood is higher than normal when they are fasting. http://ovennewyork.com/diabetes-mellitus-laboratory-tests-or-diagnostic-tests.html 21

Random blood glucose test blood glucose levels are checked at various times during the day, and it doesn’t matter when you last ate. Blood glucose levels tend to stay constant in a person who doesn’t have diabetes. http://ovennewyork.com/diabetes-mellitus-laboratory-tests-or-diagnostic-tests.html 22

Oral glucose tolerance test (OGTT) FBS is obtained before the ingestion of a 50- to 200-g glucose load (usual amount is 75 g), blood samples are drawn at ½, 1, 2, and 3 hours (may be 4- or 5-hour sampling). Blood samples are checked at regular intervals for two hours. Glucose tolerance tests are used when the results of the fasting blood glucose are borderline. This test will confirm diabetes if the person’s blood sugar levels stay high for a long time after the tests. . http://ovennewyork.com/diabetes-mellitus-laboratory-tests-or-diagnostic-tests.html 23

They are also used to diagnose diabetes in pregnancy (gestational diabetes). NORMAL: the results of the glucose tolerance test will show that their blood sugar levels fall within the normal range Patients with plasma glucose at or above 140 mg/dL or 7.8 mmol/L, but not over 200, two hours after a 75 g oral glucose load are considered to have impaired glucose tolerance. 24

Glycated Hemoglobin (Glycohemoglobin, HbA1c) for Diabetes Mellitus Measures glycemic control over a 60- to 120-day period by measuring the irreversible reaction of glucose to hemoglobin through freely permeable erythrocytes during their 120-day lifecycle. While not used for diagnosis, an elevated level of glucose irreversibly bound to hemoglobin of 6.0% or higher (the 2003 revised U.S. standard) is considered abnormal by most labs http://ovennewyork.com/diabetes-mellitus-laboratory-tests-or-diagnostic-tests.html 25

C-Peptide Assay (Connecting Peptide Assay) for Diabetes Mellitus Cleaved from the proinsulin molecule during its conversion to insulin, C-peptide acts as a marker for endogenous insulin production. http://ovennewyork.com/diabetes-mellitus-laboratory-tests-or-diagnostic-tests.html 26

Fructosamine Assay for Diabetes Mellitus Glycated protein with a much shorter half-life than glycated hemoglobin, reflecting control over a shorter period, approximately 14 to 21 days. May be advantageous in patients with hemoglobin variants that interfere with the accuracy of glycated hemoglobin tests. http://ovennewyork.com/diabetes-mellitus-laboratory-tests-or-diagnostic-tests.html 27

GOALS OF THERAPY Eliminate symptoms related to hyperglycemia Reduce or eliminate the long-term microvascular and macrovascular complications of DM Allow the patient to achieve as normal a lifestyle as possible Harrison’s 17th Edition

Patient education about DM, nutrition and exercise Patient with DM should receive education about: Nutrition Exercise Care of diabetes during illness Medications to lower the plasma glucose Continuing process with regular visits for reinforcement Diabetes self-management education (DSME) Harrison’s 17th Edition

Diabetes education Self-monitoring of blood glucose Urine ketone monitoring (type 1) Insulin administration Guidelines for diabetes management during illness Management of hypoglycemia Foot and skin care DM management before, during and after exercise Risk-factor-modifying activities Harrison’s 17th Edition

Nutrition Medical Nutrition Therapy (MNT) Modest caloric reduction Reduced fat intake Increased physical activity Reduction of hyperlipidemia and hypertension Increased consumption of soluble dietary fiber may improve glycemic control Weight loss and exercise improve insulin resistance Harrison’s 17th Edition

Exercise CV risk reduction Reduced BP Maintenance of muscle mass Reduction in body fat and weight loss Lowering plasma glucose Increasing insulin sensitivity *ADA recommends 150 min/week (distributed over at least 3 days) Harrison’s 17th Edition

Monitoring the level of glyceminc control Plasma glucose measurements by the patient and assessment of long-term control by the physician Measurement of A1C and review of the patient’s self-measurement of plasma glucose These are complementary: A1C-average glycemic control over the previous 2-3 months patient’s measurement- short term glycemic control Harrison’s 17th Edition

Self-monitoring of Blood Glucose Standard of care in diabetes management and allows the patient to monitor his/her blood glucose at any time Glucose monitors can rapidly and accurately measure glucose in small amounts of blood (3-10 µL obtained from the fingertip *individuals with type 2 DM who are taking insulin should utilize SMBG more frequently than than those on oral agents Harrison’s 17th Edition

Assessment of Long-term Glycemic Control Measurement of glycated hemoglobin Plasma glucose is consistently elevated = increase in nonenzymatic glycation of hemoglobin Reflects the glycemic history over the previous 2-3 months Harrison’s 17th Edition